NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

I understood that they raised 1 billion towards building manufacturing, but somehow didn't run the manufacturing side of the equation in a way that put the company ahead of the curve. We also know that the DNDN story is infamous, and known for being the most egregious case of naked shorting absuse known to WS. Kramer was in on it. There were ties to the mob trading in the stock. That's why I don't believe small development stage biotechs are well suited for a transition to GIA. That's where fiscal discipline can still fall short, because really, it's BP's well oiled machine that turns these new drugs into blockbusters. So far so good, because the comparison thus far has shown LP to be a formidable leader to get the treatment approved. As for post approval, it depends what structure NWBO takes on imo.

ILT